# FDA Inspection 1255311 - Andrzej Emeryk, M.D. - November 18, 2024

Source: https://www.keypedia.com/records/fda_inspections/andrzej-emeryk-md/b29dd603-8cfd-43ae-9bf8-eda576fe31bd
Source feed: FDA_Inspections

> FDA Inspection 1255311 for Andrzej Emeryk, M.D. on November 18, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255311
- Company Name: Andrzej Emeryk, M.D.
- Inspection Date: 2024-11-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1255311 - 2024-11-18](https://www.keypedia.com/records/fda_inspections/andrzej-emeryk-md/09f91bfb-f3d8-4ac4-97da-e1863ea6a81b)

Company: https://www.keypedia.com/companies/andrzej-emeryk-md/695c203f-2020-4b84-b2f4-103a21f35c2e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d